NEOS Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$154M Buy
128,460
+11,065
+9% +$11.3M 0.57% 31
2026
Q1
$108M Buy
117,395
+815
+0.7% +$826K 0.55% 33
2025
Q4
$125M Buy
116,580
+13,560
+13% +$13M 0.72% 18
2025
Q3
$78.6M Buy
103,020
+28,031
+37% +$20.9M 0.59% 25
2025
Q2
$58.5M Buy
74,989
+9,444
+14% +$7.34M 0.72% 20
2025
Q1
$54.1M Buy
65,545
+15,005
+30% +$12.5M 1.03% 14
2024
Q4
$39M Buy
50,540
+11,383
+29% +$9.43M 0.92% 14
2024
Q3
$34.7M Buy
39,157
+4,919
+14% +$4.42M 1.05% 13
2024
Q2
$31M Buy
34,238
+9,973
+41% +$7.98M 1.28% 11
2024
Q1
$18.9M Buy
24,265
+11,592
+91% +$8.25M 1.17% 11
2023
Q4
$7.39M Buy
12,673
+5,025
+66% +$2.93M 0.7% 26
2023
Q3
$4.11M Buy
+7,648
New +$3.94M 0.52% 39

Other funds holding LLY

NEOS Investment Management's LLY Position: Q2 2026 in Review

NEOS Investment Management increased its Eli Lilly (LLY) stake by 9.4% in Q2 2026, buying an estimated $11.3M and bringing the position to 128,460 shares worth $154M. The position accounts for 0.57% of the portfolio, ranked #31.

NEOS Investment Management first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • NEOS Investment Management held 128,460 shares of Eli Lilly worth $154M as of Q2 2026.
  • NEOS Investment Management bought 11,065 Eli Lilly shares in Q2 2026, an estimated $11.3M.
  • Eli Lilly made up 0.57% of NEOS Investment Management's portfolio in Q2 2026, its #31 holding.
  • NEOS Investment Management first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on NEOS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.